[go: up one dir, main page]

OA08215A - Molecule comprising at least one peptide sequence carrying an epitope characteristic of a protein produced by cells infected with malaria parasites and compositions containing them. - Google Patents

Molecule comprising at least one peptide sequence carrying an epitope characteristic of a protein produced by cells infected with malaria parasites and compositions containing them.

Info

Publication number
OA08215A
OA08215A OA58798A OA58798A OA08215A OA 08215 A OA08215 A OA 08215A OA 58798 A OA58798 A OA 58798A OA 58798 A OA58798 A OA 58798A OA 08215 A OA08215 A OA 08215A
Authority
OA
OAPI
Prior art keywords
molecule
compositions containing
peptide sequence
cells infected
protein produced
Prior art date
Application number
OA58798A
Other languages
French (fr)
Inventor
Michael Koenen
Arthur Scherf
Benno Muller-Hill
Odile Mercereau-Puijalon
Da Silva Luiz Pereira
Original Assignee
Inst Pasteur & Centre National
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Pasteur & Centre National filed Critical Inst Pasteur & Centre National
Publication of OA08215A publication Critical patent/OA08215A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
OA58798A 1984-07-02 1986-02-28 Molecule comprising at least one peptide sequence carrying an epitope characteristic of a protein produced by cells infected with malaria parasites and compositions containing them. OA08215A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8410461A FR2566780B1 (en) 1984-07-02 1984-07-02 MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING A CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY CELLS INFECTED BY MALARIA PARASITES AND COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
OA08215A true OA08215A (en) 1987-10-30

Family

ID=9305696

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58798A OA08215A (en) 1984-07-02 1986-02-28 Molecule comprising at least one peptide sequence carrying an epitope characteristic of a protein produced by cells infected with malaria parasites and compositions containing them.

Country Status (7)

Country Link
EP (1) EP0191028B1 (en)
AU (1) AU599004B2 (en)
CA (1) CA1268600A (en)
DE (1) DE3571442D1 (en)
FR (1) FR2566780B1 (en)
OA (1) OA08215A (en)
WO (1) WO1986000620A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
PT100757A (en) * 1991-07-31 1993-10-29 Pasteur Institut POLYPEPTIDES FOR INDUCING "IN VIVO" ANTIBODIES ABLE TO INHIBIT THE INVASION OF RED GLOBULES BY MERZOITOS OF "P. FALCIPARUM", APARENTED PRODUCTS AND ITS APPLICATION IN THE PRODUCTION OF VACCINATION COMPOSITIONS
WO1993012145A1 (en) * 1991-12-19 1993-06-24 Baylor College Of Medicine Pva or peg conjugates of peptides for epitope-specific immunosuppression
US5532133A (en) * 1993-06-02 1996-07-02 New York University Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays
EP1544211A1 (en) 2003-12-15 2005-06-22 Institut Pasteur LSA-5 pre-erythrocytic stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein

Also Published As

Publication number Publication date
DE3571442D1 (en) 1989-08-17
AU599004B2 (en) 1990-07-12
AU4543185A (en) 1986-02-10
EP0191028A1 (en) 1986-08-20
EP0191028B1 (en) 1989-07-12
WO1986000620A1 (en) 1986-01-30
CA1268600A (en) 1990-05-01
FR2566780A1 (en) 1986-01-03
FR2566780B1 (en) 1987-02-06

Similar Documents

Publication Publication Date Title
DE68927296D1 (en) SEMICONDUCTOR PACKINGS MADE OF ALUMINUM ALLOY
IT1174205B (en) FLUOROPLIETERI CONTAINING TERMINAL GROUPS EQUIPPED WITH ANCHORS
DE3586313D1 (en) CONJUGATES OF PHARMACEUTICAL USEFUL PROTEINS.
IT1226576B (en) SEALING OF FLOW WITHOUT CONTACT.
NL188642C (en) 3-AMINOALKYL-1H-INDOOL-5-METHANE SULFONAMIDE COMPOUND AND PHARMACEUTICAL PREPARATION WITH NECK ARTICULATING ACTION.
DE3763404D1 (en) DEPOSITION OF MERCURY FROM NATURAL GAS.
FR2679230B1 (en) NOVEL DERIVATIVES OF TAXOL ANALOGS, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM.
FI932561A0 (en) Protein with intact epithelium and pharyngeal protein
IT1232848B (en) COMPOSITION OF CLEAR SHAMPOO
DE68921156D1 (en) Connection of high temperature oxide superconductors.
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
OA08278A (en) LAV II envelope glycoprotein.
OA08215A (en) Molecule comprising at least one peptide sequence carrying an epitope characteristic of a protein produced by cells infected with malaria parasites and compositions containing them.
OA07800A (en) Polypeptide action inducing protective antibodies against malaria parasites and immunogenic compositions containing them.
FR2626175B1 (en) NOVEL 1,2-ETHYLENEDIAMINE COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
ATE74367T1 (en) PEPTIDE COMPOUND AND ANTISERUM PRODUCED BY THIS COMPOUND.
IT1170302B (en) POLYPEPTIDE HAVING INTERFERON ACTIVITY, COMPOSITION CONTAINING IT AND PREPARATION PROCEDURE
NO162611C (en) EXPLOSIVE COMPOSITION.
FR2564805B1 (en) CONTAINER COMPRISING A SUCTION STRAW
BR8506691A (en) COMPOSITIONS OF MOLECULAR SIEVE OF TITANIUM ALUMINUM-SILICON OXIDE
FR2528425B1 (en) 1,4-DIHYDROPYRIDINES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
IT8522730A0 (en) IRON-DERIVATIVES OF GLOBIN AND ACETYLGLOBIN WITH HIGH BIOAVAILABILITY, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS.
FR2562766B1 (en) REPULSIVE COMPOSITIONS AGAINST INSECTS, TIKS AND MITES CONTAINING AT LEAST ONE O-ALKYL N-PHENYLTHIOCARBAMATE AND N, N-DIETHYL-M-TOLUAMIDE
IT1185435B (en) SELF-LUBRICATING FUEL COMPOSITION BASED ON COAL AND A FRACTION OF HYDROCARBONS
EA200001252A1 (en) COMPOSITION OF THE RECOMBINANT INTERFERON-β-1A (IFN-β-1A) PERSON